Hospital
Nason Medical Center LLC
Nason Medical Center LLC was paid $1.63M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 99285, emergency room visit (most serious) — 29% of everything it billed.
33Billing provider infoNASON MEDICAL CENTER LLC
ROARING SPRING, PA 16673
ROARING SPRING, PA 16673
33aNPI1497708473assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.63M
24GClaims55,947
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#96 of 154
Median peer was paid$2.82M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 183 | $3K | |
| 2019 | 26 | $670.62 | |
| 2020 | 4,476 | $93K | |
| 2021 | 28,578 | $613K | |
| 2022 | 9,227 | $375K | |
| 2023 | 8,172 | $305K | |
| 2024incomplete | 5,285 | $238K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 29% | 3,138 | 3,038 | $469K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 4,448 | 4,366 | $324K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 2,902 | 2,829 | $309K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.7% | 789 | 758 | $60K |
| 80053 | Comprehensive metabolic panel | 2.1% | 3,588 | 3,365 | $34K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 798 | 788 | $30K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 411 | 396 | $30K |
| X0621 | 1.8% | 135 | 42 | $29K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 163 | 156 | $25K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 909 | 878 | $22K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 707 | 691 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 4,229 | 3,908 | $21K |
111 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 927 | $16K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,353 | $13K |
| 80050 | General health panel | <1% | 288 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,003 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 518 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 165 | $9K |
| 80061 | Lipid panel | <1% | 666 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 630 | $8K |
| 84484 | <1% | 889 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 851 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 915 | $6K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 464 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 169 | $5K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 145 | $5K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 70 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 210 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 377 | $5K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 14 | $5K |
| G0378 | Hospital observation service, per hour | <1% | 12 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 70 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 305 | $4K |
| 83735 | <1% | 693 | $4K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 129 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 548 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 149 | $3K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 84 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 147 | $3K |
| 87040 | <1% | 270 | $3K | |
| 84703 | <1% | 355 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 72 | $3K |
| 84702 | <1% | 176 | $3K | |
| 85027 | <1% | 366 | $2K | |
| 85610 | <1% | 821 | $2K | |
| 84439 | <1% | 314 | $2K | |
| 81001 | <1% | 955 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 147 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 83 | $2K |
| 83690 | <1% | 549 | $2K | |
| 82607 | <1% | 178 | $2K | |
| 85730 | <1% | 368 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 262 | $2K |
| 84100 | <1% | 314 | $2K | |
| 81003 | <1% | 653 | $2K | |
| 87077 | <1% | 274 | $2K | |
| 87088 | <1% | 267 | $2K | |
| 87186 | <1% | 207 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 28 | $1K |
| 59025 | Fetal non-stress test | <1% | 223 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,294 | $1K |
| 83605 | <1% | 242 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 179 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 30 | $1K |
| 85379 | <1% | 156 | $1K | |
| 82570 | <1% | 181 | $1K | |
| 80305 | <1% | 118 | $1K | |
| 87070 | <1% | 183 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 170 | $1K |
| 87081 | <1% | 228 | $1K | |
| 86762 | <1% | 52 | $1K | |
| 83880 | <1% | 48 | $1K | |
| 86803 | <1% | 59 | $1K | |
| 0002A | <1% | 31 | $956.77 | |
| 86900 | <1% | 229 | $888.57 | |
| 82043 | <1% | 124 | $872.96 | |
| 82728 | <1% | 79 | $868.38 | |
| 85007 | <1% | 207 | $794.55 | |
| 85652 | <1% | 308 | $779.65 | |
| 86850 | <1% | 104 | $771.51 | |
| 86885 | <1% | 97 | $770.25 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 41 | $768.70 |
| 87340 | <1% | 54 | $740.22 | |
| 80076 | <1% | 80 | $693.79 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $647.70 |
| 84481 | <1% | 29 | $609.42 | |
| 87807 | <1% | 46 | $596.38 | |
| 0001A | <1% | 33 | $570.77 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 28 | $558.06 |
| 86901 | <1% | 139 | $552.45 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 104 | $539.08 |
| 83540 | <1% | 61 | $500.46 | |
| 87205 | <1% | 126 | $489.75 | |
| 93000 | <1% | 26 | $450.80 | |
| 82150 | <1% | 113 | $429.00 | |
| 86140 | <1% | 161 | $424.34 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 169 | $394.25 |
| 86592 | <1% | 90 | $373.00 | |
| 82950 | <1% | 56 | $370.11 | |
| 73610 | <1% | 26 | $359.60 | |
| 84550 | <1% | 44 | $228.44 | |
| 86780 | <1% | 12 | $167.00 | |
| 81025 | <1% | 73 | $160.00 | |
| 82746 | <1% | 15 | $148.92 | |
| 83655 | <1% | 13 | $132.00 | |
| 73130 | <1% | 14 | $114.71 | |
| 73630 | <1% | 12 | $87.40 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 560 | $68.78 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 764 | $61.99 |
| J2704 | Injection, propofol, 10 mg | <1% | 440 | $57.64 |
| 82948 | <1% | 64 | $47.20 | |
| 85018 | <1% | 14 | $44.97 | |
| 85014 | <1% | 14 | $44.97 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 69 | $17.13 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 321 | $15.11 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 848 | $11.28 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $11.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 368 | $10.84 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 152 | $6.58 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 385 | $2.59 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 293 | $1.26 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 26 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.